|
Market Closed -
Euronext Paris
16:55:00 13/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 87.60 EUR | -0.43% |
|
+4.61% | +5.90% |
| 11-13 | Novo Holdings-backed Windward Bio valued at $1 billion as shares rise in Nasdaq debut | RE |
| 11-13 | Sanofi extends its winning streak, Citi raises target |  |
| Market Cap | 105B 116B 97.07B 87.58B 165B 10,920B 171B 1,166B 462B 5,833B 435B 425B 18,516B | P/E 2026 * |
13.9x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 116B 128B 107B 96.87B 183B 12,077B 189B 1,290B 511B 6,452B 481B 470B 20,479B | EV / Sales 2026 * |
2.4x | EV / Sales 2027 * | 2.16x |
| Free-Float |
88.8% | Yield 2026 * |
4.86% | Yield 2027 * | 5.13% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
CBOE
| SAN | Real-time | |
|
London S.E.
| 0O59 | Delayed | |
|
Tradegate
| SNW | Real-time | |
|
Xetra
| SNW | Delayed | |
|
Borsa Italiana
| 1SAN | End-of-day quote | |
|
Börse Stuttgart
| SNW | Delayed | |
|
Deutsche Boerse AG
| SNW | Delayed | |
|
Boerse Muenchen
| SNW | Real-time | |
|
CBOE
| 0O59 | Real-time | |
|
OTC Markets
| SNYNF | Delayed | |
|
Wiener Boerse
| SANO | End-of-day quote | |
|
Bulgaria S.E.
| SNW | End-of-day quote | |
|
Swiss Exchange
| SAN | Delayed |
Last Transcript: Sanofi
| 1 day | -0.43% | ||
| 1 week | +4.61% | ||
| Current month | +9.86% | ||
| 1 month | +21.97% | ||
| 3 months | +16.00% | ||
| 6 months | +19.61% | ||
| Current year | +5.90% |
| 1 week | 84.39 |  | 88.48 |
| 1 month | 70.88 | | 88.48 |
| Current year | 69.75 | | 88.48 |
| 1 year | 69.75 | | 90.07 |
| 3 years | 69.75 | | 110.88 |
| 5 years | 69.75 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 30/04/2026 | |
| Director of Finance/CFO | 64 | 31/03/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 29/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 27/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 27/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Sell | Executive/Senior Manager | -647 | 0.0001% | ||
| 20/08/26 | Buy | Chief Executive Officer | 1,506 | 0.0001% | ||
| 20/08/26 | Buy | Head of Human Resources | 54 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | +4.61% | -2.22% | +3.56% | 116B | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | |
| Average | +0.20% | +2.33% | +31.63% | +75.38% | 441B | |
| Weighted average by Cap. | +0.51% | +3.29% | +36.65% | +94.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48.43B 53.45B 44.8B 40.42B 76.17B 5,039B 78.86B 538B 213B 2,692B 201B 196B 8,545B | 51.68B 57.02B 47.8B 43.12B 81.27B 5,377B 84.13B 574B 228B 2,872B 214B 209B 9,117B |
| Net income | 7.64B 8.43B 7.07B 6.38B 12.02B 795B 12.44B 84.93B 33.67B 425B 31.65B 30.98B 1,348B | 9.21B 10.16B 8.52B 7.68B 14.48B 958B 14.99B 102B 40.57B 512B 38.13B 37.32B 1,625B |
| Net Debt | 11.13B 12.28B 10.29B 9.28B 17.5B 1,158B 18.11B 124B 49.01B 618B 46.07B 45.09B 1,963B | 6.83B 7.53B 6.31B 5.7B 10.73B 710B 11.11B 75.83B 30.07B 379B 28.26B 27.66B 1,204B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | €87.60 | -0.43% | 2,062,718 |
| 12/11/26 | €87.98 | +1.58% | 2,939,322 |
| 11/11/26 | €86.61 | +0.77% | 2,855,036 |
| 10/11/26 | €85.95 | +0.22% | 3,213,951 |
| 09/11/26 | €85.76 | +2.41% | 2,881,635 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
